Atlas Trials

A Study to Assess the Effect of Intravenous Dose of (aMBMC) to Subjects With Non-ischemic Heart Failure

Clinical trial NCT02467387 · COMPLETED

Trial details

NCT number
NCT02467387
Sponsor
CardioCell LLC
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Non-Ischemic Heart Failure
Start date
2014-06-01
Primary completion
2017-05-11
Enrollment
23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.